SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-20-000133
Filing Date
2020-02-20
Accepted
2020-02-20 16:12:18
Documents
2
Period of Report
2020-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k021920_8k.htm 8-K 18868
2 EXHIBIT 99.1 PRESS RELEASE OF VOLITIONRX LIMITED, DATED FEBRUARY 20, 2020 f8k021920_ex99z1.htm EX-99.1 28966
  Complete submission text file 0001078782-20-000133.txt   49110
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 20635191
SIC: 2835 In Vitro & In Vivo Diagnostic Substances